Lexaria Bioscience Corp. (LEXX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $705.9K | +52.0% |
| 2024 | $464.3K | +105.2% |
| 2023 | $226.2K | -11.4% |
| 2022 | $255.4K | -64.7% |
| 2021 | $722.7K | +129.6% |
| 2020 | $314.8K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $705.9K | +52.0% |
| 2024 | $464.3K | +105.2% |
| 2023 | $226.2K | -11.4% |
| 2022 | $255.4K | -64.7% |
| 2021 | $722.7K | +129.6% |
| 2020 | $314.8K | — |